MDB Capital Holdings, LLC Class A AI Stock Analysis
Want to see MDBH full AI Analyst Report?
MDB Capital Holdings, LLC Class A (MDBH) AI Stock Analysis
MDB Capital Holdings, LLC Class A
(NASDAQ:MDBH)
The score is held back primarily by weak financial performance (ongoing losses and cash burn) and bearish technical trends. Offsetting this, the latest earnings call outlined concrete cost-discipline measures and several potential monetization/inflection catalysts, but outcomes remain execution- and market-dependent. Valuation contributes negatively due to unprofitability and no indicated dividend support.
MDB Capital Holdings, LLC Class A (MDBH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $17.95M
- Dividend Yield
- ―
- Average Volume (3M)
- 3,678
- Price to Earnings (P/E)
- -0.8
- Beta (1Y)
- 0.74
- Revenue Growth
- 76.02%
- EPS Growth
- -405.81%
- Country
- US
- Employees
- 14
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Financial - Capital Markets
MDB Capital Holdings, LLC Class A Business Overview & Revenue Model
Company Description
MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer...
MDB Capital Holdings, LLC Class A Earnings Call Summary
The call presents a cautiously optimistic outlook: management acknowledges clear and material market headwinds (valuation pressure, fewer launches, modest H1 transactions and a smaller-than-expected eXoZymes financing) but highlights several concrete near-term catalysts (Paulex IPO and 2027 data readouts, PatentVest spin-out, Public Ventures partnership discussions, and eXoZymes manufacturing/commercialization advances). The tone emphasizes operational discipline (targeting $5–6M annual OpEx), non-dilutive monetization strategies, and multiple value-inflection events that could materially re-rate MDB if executed. Given the balance of tangible near-term catalysts and actions to reduce dilution against the ongoing market challenges and execution risks, the call leans positive but remains cautious.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Guidance from the call was to prioritize monetizing four core assets and running a very lean public company rather than raising new capital: target run-rate operating expenses of $5–6 million per year (about $6M after planned spinouts/partnerships), offset by fee income and aiming to avoid dilution; spin out/financing for PatentVest and pursue a partner or sale for Public Ventures (discussions/LOIs with ~4–5 parties, target to wrap in the next quarter); expect Paulex to file an IPO registration and target an IPO in Q4 with key clinical readouts in early 2027; eXoZymes is closing manufacturing and commercial partnerships (OpEx ~ $10M/year) and MDB holds ~4.1M shares (+ warrants) of eXoZymes and ~7.1M shares (+ warrants) of Paulex while owning 100% of Public Ventures and PatentVest; MDB noted two transactions in H1 (including Ticketplus) with a pipeline that could produce ~2 transactions in H2 and at least one potentially significant fee transaction, and reminded investors there are roughly 1,000 sub-$200M public companies (about 2% of market cap) amid a market where ~70% of funding has flowed to AI and the Russell Microcap’s average market cap exceeds $2.5B.
MDB Capital Holdings, LLC Class A Financial Statement Overview
Summary
Strong recent revenue growth and a low-debt balance sheet are positives, but they are outweighed by persistent losses (negative gross profit and sizable operating losses) and consistently negative operating/free cash flow, indicating ongoing cash burn and elevated execution risk.
Income Statement
18Very NegativeBalance Sheet
72PositiveCash Flow
22Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.51M | 4.28M | 2.22M | 4.23M | 1.12M | 0 |
| Gross Profit | -641.98K | -10.69M | -17.84M | -4.39M | -1.71M | -1.97M |
| EBITDA | -21.09M | -16.95M | 12.33M | -9.76M | -5.97M | -5.67M |
| Net Income | -22.46M | -21.25M | 11.69M | -6.97M | -5.31M | -15.10M |
Balance Sheet | ||||||
| Total Assets | 50.77M | 63.74M | 71.98M | 42.99M | 25.70M | 8.25M |
| Cash, Cash Equivalents and Short-Term Investments | 9.92M | 13.22M | 20.44M | 6.11M | 4.95M | 6.23M |
| Total Debt | 553.00K | 609.00K | 711.50K | 2.42M | 1.42M | 720.63K |
| Total Liabilities | 1.26M | 3.16M | 1.90M | 5.67M | 2.59M | 1.49M |
| Stockholders Equity | 49.62M | 60.69M | 70.16M | 37.31M | 22.64M | 6.24M |
Cash Flow | ||||||
| Free Cash Flow | -8.94M | -5.73M | -8.49M | -7.60M | -6.77M | -6.26M |
| Operating Cash Flow | -8.81M | -5.68M | -9.04M | -7.16M | -6.57M | -5.83M |
| Investing Cash Flow | 854.43K | -49.00K | 22.89M | -8.20M | -16.38M | -423.39K |
| Financing Cash Flow | 0 | 0 | 69.30K | 17.76M | 21.68M | 0 |
MDB Capital Holdings, LLC Class A Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MDBH, the sentiment is Neutral. The current price of 1.72 is above the 20-day moving average (MA) of 1.66, below the 50-day MA of 2.16, and below the 200-day MA of 2.96, indicating a neutral trend. The MACD of -0.17 indicates Negative momentum. The RSI at 47.66 is Neutral, neither overbought nor oversold. The STOCH value of 74.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MDBH.
MDB Capital Holdings, LLC Class A Risk Analysis
MDB Capital Holdings, LLC Class A disclosed 70 risk factors in its most recent earnings report. MDB Capital Holdings, LLC Class A reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksMDB Capital Holdings, LLC Class A Peers Comparison
Overall Rating
COHN66Neutral- MDBH52Neutral
SIEB49Neutral
DOMH43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| COHN | 66Neutral | $34.52M | 1.14 | 33.24% | 33.64% | 111.47% | 762.68% |
| MDBH | 52Neutral | $15.66M | -0.79 | -39.69% | ― | 76.02% | -405.81% |
| SIEB | 49Neutral | $76.43M | -68.86 | -1.26% | ― | 21.62% | -111.45% |
| DOMH | 43Neutral | $20.16M | -0.07 | -537.57% | ― | -11.35% | -283.65% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MDBH | MDB Capital Holdings, LLC Class A | 1.72 | -1.88 | -52.25% | |
| COHN | Cohen & Company | 11.00 | -0.63 | -5.45% | |
| SIEB | Siebert Financial | 1.88 | -0.90 | -32.37% | |
| DOMH | Dominari Holdings Inc. | 0.86 | -3.32 | -79.42% | |
| TOP | Zhong Yang Financial Group Ltd. | 14.61 | 9.36 | 178.29% | |
| GSIW | Garden Stage Ltd. | 10.17 | -21.03 | -67.40% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026